Tylosin is an antibiotic that belongs to the class of macrolide antibiotics. It functions by binding to 50S ribosomal subunit and then interacts with 23S RNA thereby blocking aminoacyl-tRNA, which in turn inhibits protein synthesis. Tylosin is manufactured by fermentation of the bacterium— Streptomyces fradiae and is most effective against gram-positive bacteria compared to gram negative bacteria. The antibiotics is used to treat various infections in animals and respiratory infections in animals caused by Pasteurella multocida, Mannheimia haemolytica, and Haemophilus spp.
According to a report by Canadian Food Inspection Agency, 2014, 11 concentrations of tylosin used for therapeutic purposes, range from 44 mg kg-1 to 110 mg kg-1 feed. Moreover, tylosin is used in pigs to treat porcine proliferative enteropathy caused by Lawsonia intracellularis — a Gram-negative bacterium. Agriculture grade Tylosin consists of 80-90% tylosin A, with smaller amounts of tylosin B, tylosin C, and tylosin D. Around 29% of the active tylosin can be recovered in fecal samples in animals that receive tylosin, orally.
Increasing demand for healthy livestock is expected to support growth of global Tylosin market over the forecast period
The demand for livestock animals for consumption is on the rise worldwide and is expected to maintain the positive growth in demand over the forecast period. Subsequently, the demand for infection-free and healthy livestock used primarily for consumption is increasing. However, the prevalence of various microbial infections is high in both humans and animals. For instance, according to the Centers for Disease Control and Prevention (CDC), 2017, zoonotic diseases are common in the U.S. and worldwide and over 6 out of every 10 known infectious diseases in humans are spread from animals. Hence, antibiotics are an important medication for livestock that aide in providing healthy food products for consumption in humans.
Detailed Segmentation:
• Global Tylosin Market, By Drug Type:
◦ Tylosin Phosphate
◦ Tylosin Tartrate
◦ Others
• Global Tylosin Market, By Application:
◦ Felines
◦ Canines
◦ Livestock
◦ Others
• Global Tylosin Market, By Route Of Administration:
◦ Oral
◦ Injectable
• Global Tylosin Market, By Geography:
◦ North America
◦ Europe
◦ Asia Pacific
◦ Latin America
◦ Middle East
◦ Africa

Global Key Players:
Key companies covered as a part of this study include, Zoetis, Tairui Pharmaceuticals, Lukang Pharmaceutical, Henan Hualun, Qilu Pharmaceutical (Inner Mongolia) Co., Ltd, Huvepharma, AdvaCare Pharma, and Elanco Animal Health.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]